C4 Therapeutics Berita Eulerpool

C4 Therapeutics Berita Saham

C4 Therapeutics diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini C4 Therapeutics kami rangkum di sini.

• 20 November ·

  Yahoo
  C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
• 6 November ·

  SeekingAlpha
  C4 Therapeutics: Holding Fast To A Generous Valuation Heading Into An Important ASH Readout
• 6 November ·

  Yahoo
  C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
• 5 November ·

  Yahoo
  C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
• 1 November ·

  Yahoo
  C4 Therapeutics Third Quarter 2024 Earnings: Beats Expectations
• 1 November ·

  TipRanks
  Analysts’ Top Healthcare Picks: C4 Therapeutics (CCCC), Alnylam Pharma (ALNY)
• 31 Oktober ·

  TipRanks
  C4 Therapeutics Advances in Protein Degradation Therapy
• 31 Oktober ·

  Yahoo
  C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
• 31 Oktober ·

  Seeking Alpha
  C4 Therapeutics GAAP EPS of -$0.35 beats by $0.05, revenue of $15.36M beats by $10.76M
• 31 Oktober ·

  GuruFocus
  C4 Therapeutics (CCCC) Q3 2024 Earnings: Revenue Surges to $15.4M, GAAP EPS Loss Narrows to $0.35